US Stock MarketDetailed Quotes

CABA Cabaletta Bio

Watchlist
  • 2.820
  • -0.120-4.08%
Close Dec 13 16:00 ET
  • 2.868
  • +0.048+1.71%
Post 19:54 ET
137.83MMarket Cap-1.31P/E (TTM)

Cabaletta Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
77.02%33.05M
90.55%30.28M
65.32%28.03M
37.90%74.66M
41.98%23.15M
58.50%18.67M
21.67%15.89M
30.44%16.96M
16.90%54.14M
17.34%16.3M
Selling and administrative expenses
38.41%6.76M
67.41%6.85M
34.42%6.08M
29.63%19.24M
47.13%5.74M
37.03%4.88M
15.43%4.09M
18.07%4.52M
7.38%14.84M
-1.81%3.9M
-General and administrative expense
38.41%6.76M
67.41%6.85M
34.42%6.08M
29.63%19.24M
47.13%5.74M
37.03%4.88M
15.43%4.09M
18.07%4.52M
7.38%14.84M
-1.81%3.9M
Research and development costs
90.69%26.29M
98.58%23.43M
76.55%21.95M
41.03%55.42M
40.36%17.41M
67.81%13.79M
24.00%11.8M
35.61%12.44M
20.95%39.3M
25.01%12.4M
Operating profit
-77.02%-33.05M
-90.55%-30.28M
-65.32%-28.03M
-37.90%-74.66M
-41.98%-23.15M
-58.50%-18.67M
-21.67%-15.89M
-30.44%-16.96M
-16.90%-54.14M
-17.34%-16.3M
Net non-operating interest income expense
8.87%2.42M
90.81%2.68M
170.78%2.98M
500.09%6.99M
270.49%2.26M
532.48%2.22M
835.33%1.4M
1,979.25%1.1M
4,750.00%1.16M
12,100.00%610K
Non-operating interest income
8.87%2.42M
90.81%2.68M
170.78%2.98M
500.09%6.99M
270.49%2.26M
532.48%2.22M
835.33%1.4M
1,979.25%1.1M
4,750.00%1.16M
12,100.00%610K
Other net income (expense)
Income before tax
-86.22%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-33.10%-20.89M
-43.94%-16.45M
-12.22%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-12.99%-15.69M
Income tax
Net income
-86.22%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-33.10%-20.89M
-43.94%-16.45M
-12.22%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-12.99%-15.69M
Net income continuous Operations
-86.22%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-33.10%-20.89M
-43.94%-16.45M
-12.22%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-12.99%-15.69M
Minority interest income
Net income attributable to the parent company
-86.22%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-33.10%-20.89M
-43.94%-16.45M
-12.22%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-12.99%-15.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-94.40%-30.63M
-90.53%-27.6M
-57.99%-25.05M
-27.75%-67.68M
-12.89%-23.08M
-56.26%-15.76M
-28.04%-14.49M
-22.46%-15.85M
-14.44%-52.98M
-47.24%-20.45M
Basic earnings per share
-67.57%-0.62
-51.35%-0.56
-13.33%-0.51
8.84%-1.65
9.62%-0.47
5.13%-0.37
17.78%-0.37
0.00%-0.45
-0.56%-1.81
-6.12%-0.52
Diluted earnings per share
-67.57%-0.62
-51.35%-0.56
-13.33%-0.51
8.84%-1.65
9.62%-0.47
5.13%-0.37
17.78%-0.37
0.00%-0.45
-0.56%-1.81
-6.12%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 77.02%33.05M90.55%30.28M65.32%28.03M37.90%74.66M41.98%23.15M58.50%18.67M21.67%15.89M30.44%16.96M16.90%54.14M17.34%16.3M
Selling and administrative expenses 38.41%6.76M67.41%6.85M34.42%6.08M29.63%19.24M47.13%5.74M37.03%4.88M15.43%4.09M18.07%4.52M7.38%14.84M-1.81%3.9M
-General and administrative expense 38.41%6.76M67.41%6.85M34.42%6.08M29.63%19.24M47.13%5.74M37.03%4.88M15.43%4.09M18.07%4.52M7.38%14.84M-1.81%3.9M
Research and development costs 90.69%26.29M98.58%23.43M76.55%21.95M41.03%55.42M40.36%17.41M67.81%13.79M24.00%11.8M35.61%12.44M20.95%39.3M25.01%12.4M
Operating profit -77.02%-33.05M-90.55%-30.28M-65.32%-28.03M-37.90%-74.66M-41.98%-23.15M-58.50%-18.67M-21.67%-15.89M-30.44%-16.96M-16.90%-54.14M-17.34%-16.3M
Net non-operating interest income expense 8.87%2.42M90.81%2.68M170.78%2.98M500.09%6.99M270.49%2.26M532.48%2.22M835.33%1.4M1,979.25%1.1M4,750.00%1.16M12,100.00%610K
Non-operating interest income 8.87%2.42M90.81%2.68M170.78%2.98M500.09%6.99M270.49%2.26M532.48%2.22M835.33%1.4M1,979.25%1.1M4,750.00%1.16M12,100.00%610K
Other net income (expense)
Income before tax -86.22%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-33.10%-20.89M-43.94%-16.45M-12.22%-14.49M-22.46%-15.85M-14.44%-52.98M-12.99%-15.69M
Income tax
Net income -86.22%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-33.10%-20.89M-43.94%-16.45M-12.22%-14.49M-22.46%-15.85M-14.44%-52.98M-12.99%-15.69M
Net income continuous Operations -86.22%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-33.10%-20.89M-43.94%-16.45M-12.22%-14.49M-22.46%-15.85M-14.44%-52.98M-12.99%-15.69M
Minority interest income
Net income attributable to the parent company -86.22%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-33.10%-20.89M-43.94%-16.45M-12.22%-14.49M-22.46%-15.85M-14.44%-52.98M-12.99%-15.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -94.40%-30.63M-90.53%-27.6M-57.99%-25.05M-27.75%-67.68M-12.89%-23.08M-56.26%-15.76M-28.04%-14.49M-22.46%-15.85M-14.44%-52.98M-47.24%-20.45M
Basic earnings per share -67.57%-0.62-51.35%-0.56-13.33%-0.518.84%-1.659.62%-0.475.13%-0.3717.78%-0.370.00%-0.45-0.56%-1.81-6.12%-0.52
Diluted earnings per share -67.57%-0.62-51.35%-0.56-13.33%-0.518.84%-1.659.62%-0.475.13%-0.3717.78%-0.370.00%-0.45-0.56%-1.81-6.12%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List